Acticor Biotech
ALACT | PA
Overview
Corporate Details
- ISIN(s):
- FR0012519668 (+1 more)
- LEI:
- 969500K433EK1G89EV95
- Country:
- France
- Address:
- 82 AVENUE DU MAINE, 75014 PARIS
- Website:
- https://www.acticor-biotech.com
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Acticor Biotech is a spin-off from Inserm (French National Institute of Health and Medical Research) dedicated to the development of an innovative therapeutic strategy for a safe and effective emergency treatment of ischemic strokes which account for 80% of all strokes. Acticor Biotech’s project stems from the sheer need for new therapeutic options to manage stroke. According to the World Health Organization, 15 million people suffer stroke worldwide each year. Of these, 5 million die and another 5 million are permanently disabled. Stroke is the third cause of death in the world and the leading cause of death among women. It is also the first cause of adult acquired disabilities resulting from the neurological damages sustained by 75% of the survivors.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Acticor Biotech.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-01-06 08:00 |
Legal Proceedings Report
Inside Information / Other news releases
|
English | 171.0 KB | |
| 2025-01-06 08:00 |
Legal Proceedings Report
Informations privilégiées / Autres communiqués
|
French | 169.3 KB | |
| 2024-12-19 18:00 |
Legal Proceedings Report
Informations privilégiées / Autres communiqués
|
French | 205.7 KB | |
| 2024-12-19 18:00 |
Legal Proceedings Report
Inside Information / Other news releases
|
English | 214.6 KB | |
| 2024-12-10 18:00 |
Legal Proceedings Report
Informations privilégiées / Autres communiqués
|
French | 202.1 KB | |
| 2024-12-10 18:00 |
Legal Proceedings Report
Inside Information / Other news releases
|
English | 214.1 KB | |
| 2024-11-06 08:30 |
Legal Proceedings Report
Inside Information / Other news releases
|
English | 177.1 KB | |
| 2024-11-06 08:30 |
Legal Proceedings Report
Informations privilégiées / Autres communiqués
|
French | 179.2 KB | |
| 2024-11-04 11:46 |
Earnings Release
Inside Information / News release on accounts, results
|
English | 322.8 KB | |
| 2024-11-04 11:46 |
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
|
French | 311.2 KB | |
| 2024-10-31 17:45 |
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
|
French | 400.7 KB | |
| 2024-10-31 17:45 |
Interim Report
Inside Information / News release on accounts, results
|
English | 464.4 KB | |
| 2024-10-16 17:45 |
Legal Proceedings Report
Inside Information / Other news releases
|
English | 289.1 KB | |
| 2024-10-16 17:45 |
Legal Proceedings Report
Informations privilégiées / Autres communiqués
|
French | 223.1 KB | |
| 2024-10-14 08:00 |
Board/Management Information
Informations privilégiées / Autres communiqués
|
French | 275.7 KB |
Automate Your Workflow. Get a real-time feed of all Acticor Biotech filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Acticor Biotech via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Urteste S.A. | Poland | URT | |
|
Valbiotis | France | ALVAL | |
|
VALIRX PLC | United Kingdom | VAL | |
|
Vaxxa AB | Sweden | VAXXA | |
| Vision Sigma Ltd. | Israel | VISN | ||
|
Vivoryon Therapeutics N.V. | Germany | VVY | |
|
Vytrus Biotech S.A. | Spain | VYT | |
|
WntResearch AB | Sweden | WNT | |
|
Xbrane Biopharma | Sweden | XBRANE | |
|
Xintela AB | Sweden | XINT |